Advances in the Management of Platinum-Sensitive Relapsed Ovarian Cancer
Author:
Affiliation:
1. Beth Israel Medical Center and Harvard Medical School, Boston, MA
2. Association of Research on Cancers Including Gynecological–Group of National Investigators for the Study of Ovarian Cancer and Breast, Paris, France
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.00314
Reference56 articles.
1. Cancer of the Ovary
2. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
3. Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent
4. Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
5. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Poly(ADP-ribose) polymerase inhibitors in the treatment landscape of triple-negative breast cancer (TNBC);Journal of Oncology Pharmacy Practice;2023-08-09
2. Patient-reported outcomes of maintenance rucaparib in patients with recurrent ovarian carcinoma in ARIEL3, a phase III, randomized, placebo-controlled trial;GYNECOL ONCOL;2023
3. Patient-reported outcomes of maintenance rucaparib in patients with recurrent ovarian carcinoma in ARIEL3, a phase III, randomized, placebo-controlled trial;Gynecologic Oncology;2023-08
4. Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon;Gynecologic Oncology Reports;2023-06
5. Switchable nanoparticles complexing cisplatin for circumventing glutathione depletion in breast cancer chemotherapy;Chinese Chemical Letters;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3